RELX Plc Executive Joins Smith+Nephew’s Board

Smith+Nephew has appointed Sybella Stanley to its board as an independent non-executive director, effective Feb. 1. She will serve as a member of the Remuneration Committee and succeed Angie Risley as committee chair beginning June 30.

“We are delighted to welcome Sybella to our board. Her broad experience in successful global businesses in both senior management and non-executive capacities will further strengthen the board,” Chairman Rupert Soames said. “This appointment reflects Smith+Nephew’s commitment to succession planning, bringing together a range of diverse talent, expertise, skills and experience, and ensuring the effective transition of responsibilities.”

Stanley has worked for RELX Plc since 1997 and is currently director of Corporate Finance. She retired in December 2024 from the board of Tate & Lyle plc after serving nine years as an independent non-executive director and Remuneration Committee chair. She served for nine years as an independent non-executive director of Merchants Trust Plc and as senior independent director and Remuneration Committee chair until her March 2024 retirement. She also co-chairs the Development Board at Somerville College, Oxford.

Smith+Nephew is focused on the repair, regeneration and replacement of soft and hard tissue. Its 18,000 employees develop and manufacture new technologies across the company’s three global business units—Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Founded in Hull, U.K., in 1856, Smith+Nephew operates in more than 100 countries, and generated $5.5 billion in 2023 sales. Smith+Nephew is a constituent of the FTSE100.